P3 Health Partners assumed with a Buy at Lake Street

Lake Street assumed coverage of P3 Health Partners (PIII) with a Buy rating and $20 price target Despite first half revenue declining versus the prior year, Q2 results showed “encouraging signs,” the analyst tells investors. 2025 remains a transitional year as the P3 sets up for a “transformational 2026,” the analyst added.